# PCYT1A

## Overview
PCYT1A is a gene that encodes the enzyme CTP:phosphocholine cytidylyltransferase α (CCTα), which is a key regulator in the biosynthesis of phosphatidylcholine, the most prevalent phospholipid in eukaryotic cell membranes. This enzyme is categorized as a cytidylyltransferase and is responsible for catalyzing the rate-limiting step in the Kennedy pathway, a critical process for membrane biogenesis and lipid metabolism (Wang2005Early; Payne2014Mutations). The protein encoded by PCYT1A is primarily localized in the nucleus, where it plays a vital role in sensing and responding to membrane stress by adjusting phosphatidylcholine content, thus maintaining membrane integrity and cellular homeostasis (Haider2018PCYT1A). Mutations in PCYT1A have been linked to various clinical conditions, including congenital lipodystrophy and spondylometaphyseal dysplasia with cone-rod dystrophy, underscoring its importance in normal physiological processes and disease states (Jurgens2019Loss; Payne2014Mutations).

## Structure
The PCYT1A gene encodes an enzyme that plays a crucial role in phosphatidylcholine biosynthesis. The protein structure of PCYT1A includes several distinct domains that contribute to its function. The primary structure of PCYT1A consists of amino acid sequences that form specific functional domains. These include a nuclear localization signal in the amino terminal region, a catalytic core responsible for substrate binding, a phospholipid sensor domain that regulates enzyme activity, and a carboxy terminal region containing phosphorylation sites (Karim2003Gene).

The secondary structure of PCYT1A involves motifs that fold into amphipathic helices upon encountering specific membrane features. This folding is crucial for the enzyme's activation and membrane association, as it allows substrate access to the catalytic pocket (Haider2018PCYT1A). The tertiary structure of PCYT1A is characterized by its ability to exist in both soluble and membrane-associated forms, with its catalytic activity being enhanced upon membrane association (Haider2018PCYT1A).

PCYT1A also undergoes post-translational modifications, such as phosphorylation, which play a role in its regulation (Karim2003Gene). The gene produces multiple splice variant isoforms, including a newly identified murine isoform, CCTh3, which expands the number of CCT protein isoforms (Karim2003Gene).

## Function
The PCYT1A gene encodes the enzyme CTP:phosphocholine cytidylyltransferase α (CCTα), which plays a crucial role in the biosynthesis of phosphatidylcholine (PC), the most abundant phospholipid in eukaryotic cell membranes. This enzyme catalyzes the rate-limiting step in the Kennedy pathway, converting phosphocholine and CTP to CDP-choline, which is then used to produce PC (Wang2005Early; Payne2014Mutations). PC is essential for maintaining cellular membrane integrity and function, influencing processes such as membrane biogenesis, lipid metabolism, and cell signaling (Cornell2015CTP:phosphocholine).

PCYT1A is primarily active in the nucleus and is involved in sensing and adjusting membrane PC content in response to membrane stress. It detects membrane packing defects and binds to the membrane, catalyzing the synthesis of CDP-choline to stabilize the membrane (Haider2018PCYT1A). This activity is crucial for maintaining membrane phospholipid homeostasis and is particularly important in tissues with high PC demands, such as the liver and adipose tissue (Haider2018PCYT1A). The enzyme's function is vital for cell growth, organelle function, and overall cellular health (Jurgens2019Loss).

## Clinical Significance
Mutations in the PCYT1A gene are associated with several clinical conditions due to its role in phosphatidylcholine biosynthesis. Biallelic loss-of-function mutations in PCYT1A can lead to congenital lipodystrophy, severe fatty liver disease, low HDL cholesterol levels, insulin resistance, and diabetes. These conditions highlight the importance of PCYT1A-generated phosphatidylcholine in normal white adipose tissue function and insulin action (Payne2014Mutations).

PCYT1A mutations are also linked to spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), a rare autosomal recessive disorder characterized by skeletal abnormalities and retinal degeneration. Variants in PCYT1A result in reduced enzyme activity, affecting lipid metabolism and chondrocyte differentiation, which are crucial for normal skeletal and visual development (HooverFong2014Mutations; Jurgens2019Loss).

Alterations in PCYT1A expression have been implicated in lung adenocarcinoma, where the gene acts as a negative regulator of the mTORC1 signaling pathway. Reduced expression of PCYT1A enhances cancer cell proliferation and migration, suggesting its potential role as a tumor suppressor (Yu2020PCYT1A).

## Interactions
PCYT1A, also known as CTP:phosphocholine cytidylyltransferase, is involved in several interactions that are crucial for its function in phosphatidylcholine biosynthesis and cellular processes. It interacts with lipid droplets (LDs), which is essential for its localization and function in lipid metabolism. Mutations in PCYT1A, such as the E280del mutation, can disrupt these interactions by affecting the protein's ability to associate with phospholipid membranes, highlighting the importance of its amphipathic helical region for membrane binding (Payne2014Mutations).

PCYT1A also plays a role in the mTORC1 signaling pathway, where it acts as a negative regulator. It suppresses cell proliferation and migration by inhibiting mTORC1 signaling. When PCYT1A is knocked down, mTORC1 signaling is activated, promoting cell proliferation and migration. This interaction is mediated through the mTORC1 complex component RAPTOR, as silencing RAPTOR diminishes mTORC1 signaling and reverses the effects of PCYT1A knockdown (Yu2020PCYT1A).

These interactions underscore PCYT1A's role in both lipid metabolism and cellular signaling pathways, contributing to its function in maintaining cellular homeostasis and its potential implications in diseases such as cancer and lipodystrophy.


## References


[1. (Karim2003Gene) Mohammad Karim, Pam Jackson, and Suzanne Jackowski. Gene structure, expression and identification of a new ctp:phosphocholine cytidylyltransferase β isoform. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1633(1):1–12, July 2003. URL: http://dx.doi.org/10.1016/s1388-1981(03)00067-2, doi:10.1016/s1388-1981(03)00067-2. This article has 79 citations.](https://doi.org/10.1016/s1388-1981(03)00067-2)

[2. (Haider2018PCYT1A) Afreen Haider, Yu-Chen Wei, Koini Lim, Antonio D. Barbosa, Che-Hsiung Liu, Ursula Weber, Marek Mlodzik, Kadri Oras, Simon Collier, M. Mahmood Hussain, Liang Dong, Satish Patel, Anna Alvarez-Guaita, Vladimir Saudek, Benjamin J. Jenkins, Albert Koulman, Marcus K. Dymond, Roger C. Hardie, Symeon Siniossoglou, and David B. Savage. Pcyt1a regulates phosphatidylcholine homeostasis from the inner nuclear membrane in response to membrane stored curvature elastic stress. Developmental Cell, 45(4):481-495.e8, May 2018. URL: http://dx.doi.org/10.1016/j.devcel.2018.04.012, doi:10.1016/j.devcel.2018.04.012. This article has 112 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.devcel.2018.04.012)

[3. (Wang2005Early) Limin Wang, Susan Magdaleno, Ira Tabas, and Suzanne Jackowski. Early embryonic lethality in mice with targeted deletion of the ctp:phosphocholine cytidylyltransferase α gene (pcyt1a). Molecular and Cellular Biology, 25(8):3357–3363, April 2005. URL: http://dx.doi.org/10.1128/MCB.25.8.3357-3363.2005, doi:10.1128/mcb.25.8.3357-3363.2005. This article has 129 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.25.8.3357-3363.2005)

[4. (Payne2014Mutations) Felicity Payne, Koini Lim, Amandine Girousse, Rebecca J. Brown, Nora Kory, Ann Robbins, Yali Xue, Alison Sleigh, Elaine Cochran, Claire Adams, Arundhati Dev Borman, David Russel-Jones, Phillip Gorden, Robert K. Semple, Vladimir Saudek, Stephen O’Rahilly, Tobias C. Walther, Inês Barroso, and David B. Savage. Mutations disrupting the kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease. Proceedings of the National Academy of Sciences, 111(24):8901–8906, June 2014. URL: http://dx.doi.org/10.1073/pnas.1408523111, doi:10.1073/pnas.1408523111. This article has 121 citations.](https://doi.org/10.1073/pnas.1408523111)

[5. (HooverFong2014Mutations) Julie Hoover-Fong, Nara Sobreira, Julie Jurgens, Peggy Modaff, Carrie Blout, Ann Moser, Ok-Hwa Kim, Tae-Joon Cho, Sung Yoon Cho, Sang Jin Kim, Dong-Kyu Jin, Hiroshi Kitoh, Woong-Yang Park, Hua Ling, Kurt N. Hetrick, Kimberly F. Doheny, David Valle, and Richard M. Pauli. Mutations in pcyt1a, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy. The American Journal of Human Genetics, 94(1):105–112, January 2014. URL: http://dx.doi.org/10.1016/j.ajhg.2013.11.018, doi:10.1016/j.ajhg.2013.11.018. This article has 51 citations.](https://doi.org/10.1016/j.ajhg.2013.11.018)

[6. (Yu2020PCYT1A) Jing Yu, Changtao Wu, Qi Wu, Jiafeng Huang, Wenjuan Fu, Xuemei Xie, Wen Li, Weizhong Tang, Chuan Xu, and Guoxiang Jin. Pcyt1a suppresses proliferation and migration via inhibiting mtorc1 pathway in lung adenocarcinoma. Biochemical and Biophysical Research Communications, 529(2):353–361, August 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.05.164, doi:10.1016/j.bbrc.2020.05.164. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.05.164)

7. (Jurgens2019Loss) Loss of function variants inPCYT1Acausing spondylometaphyseal dysplasia with cone/rod dystrophy have broad consequences on lipid metabolism, chondrocyte differentiation, and lipid droplet formation. This article has 0 citations.

[8. (Cornell2015CTP:phosphocholine) Rosemary B. Cornell and Neale D. Ridgway. Ctp:phosphocholine cytidylyltransferase: function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis. Progress in Lipid Research, 59:147–171, July 2015. URL: http://dx.doi.org/10.1016/j.plipres.2015.07.001, doi:10.1016/j.plipres.2015.07.001. This article has 113 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.plipres.2015.07.001)